• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fulcrum Therapeutics, Inc. - Common Stock (NQ:FULC)

6.730 -0.170 (-2.46%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Fulcrum Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Avis Budget Group Posts Downbeat Earnings, Joins SoFi Technologies, Seagate And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
July 30, 2025
 
Via Benzinga
Whirlpool Posts Downbeat Earnings, Joins Harmonic, Stanley Black & Decker And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
July 29, 2025
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 29, 2025
 
Via Benzinga
Why Celestica Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
July 29, 2025
 
Via Benzinga
Earnings Scheduled For May 1, 2025
May 01, 2025
 
Via Benzinga
Earnings Scheduled For February 25, 2025
February 25, 2025
 
Via Benzinga
Expert Ratings For Fulcrum Therapeutics
November 14, 2024
 
Via Benzinga
Curious about the stocks that are showing activity after the closing bell on Monday?
July 28, 2025
After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session. 
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 23, 2025
 
Via Benzinga
Uncovering Potential: Fulcrum Therapeutics's Earnings Preview
April 30, 2025
 
Via Benzinga
Which stocks are moving before the opening bell on Tuesday?
April 22, 2025
Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
Earnings Scheduled For November 13, 2024
November 13, 2024
 
Via Benzinga
Earnings Preview: Fulcrum Therapeutics
November 12, 2024
 
Via Benzinga
Fulcrum Therapeutics's Earnings Outlook
November 12, 2024
 
Via Benzinga
Bristol Myers Acquired MyoKardia Drops Fulcrum Agreement, Ending Cardiomyopathy Research Deal
March 05, 2025
MyoKardia, a Bristol Myers unit, is terminating its agreement with Fulcrum Therapeutics, ending a cardiomyopathy research deal set to expire in June 2025. 
Via Benzinga
These stocks are moving in today's pre-market session
February 26, 2025
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
Avidity Biosciences, Up 441%, Nears Another Record High As Dystrophy Space Heats Up
October 18, 2024
The company is working on treatments for forms of muscular dystrophy, and is taking on some of the biggest names in pharma. 
Via Investor's Business Daily
12 Health Care Stocks Moving In Thursday's Intraday Session
September 26, 2024
 
Via Benzinga
Breaking Down Fulcrum Therapeutics: 7 Analysts Share Their Views
September 13, 2024
 
Via Benzinga
Deep Dive Into Fulcrum Therapeutics Stock: Analyst Perspectives (4 Ratings)
May 13, 2024
 
Via Benzinga
Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit.
September 26, 2024
Pfizer stock dipped Thursday after the company voluntarily pulled its sickle cell drug, Oxbryta, from the market following patient deaths. 
Via Investor's Business Daily
Wall Street's Top 10 Stock Calls This Week - Saturday, Sept. 14
September 14, 2024
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Sept. 9-13, 2024. 
Via Talk Markets
Dow Surges Over 100 Points; ModivCare Shares Plummet
September 12, 2024
 
Via Benzinga
Topics Stocks
Crude Oil Surges 3%; Kroger Posts Upbeat Earnings
September 12, 2024
 
Via Benzinga
Fulcrum Therapeutics Suspends Rare Muscular Disease Candidate After Disappointing Data From Pivotal Trial
September 12, 2024
Fulcrum Therapeutics stock drops after Phase 3 REACH trial of losmapimod flops in Facioscapulohumeral Muscular Dystrophy. The company consider suspending the program. 
Via Benzinga
US Stocks Mixed; Producer Prices Increase In August
September 12, 2024
 
Via Benzinga
Fulcrum Therapeutics Upgraded: BofA Debates Pivotal Study Success For Losmapimod In Rare Genetic Muscle Disease
September 09, 2024
BofA Securities upgraded Fulcrum Therapeutics ahead of its phase 3 losmapimod results for Facioscapulohumeral muscular dystrophy, boosting the price target from $5 to $10 due to increased confidence in... 
Via Benzinga
8 Health Care Stocks With Whale Alerts In Today's Session
August 01, 2024
 
Via Benzinga
Top 3 Health Care Stocks That Should Keep You Up At Night This Quarter
July 16, 2024
 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
June 11, 2024
 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap